Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy
Kardiologia Polska · 26.08.2023 · 81 (7-8) · 692-699
DOI: 10.33963/kp.a2023.0103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kardiologia Polska, online erschienen am 26.08.2023. Verfasst von Aleksandra Karabinowska-Małocha und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland. akarabinowska@gmail.com. Hauptthemen laut MEDLINE: Galectin 3, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND: Cardiac fibrosis is a hallmark of hypertrophic cardiomyopathy (HCM) and has confirmed unfavorable clinical significance. Replacement fibrosis is better known and has already been studied on a larger scale, whereas interstitial fibrosis is less explored. AIMS: We aimed to analyze the relationship between serum biomarkers and interstitial fibrosis, as assessed with cardiac magnetic resonance (CMR) in HCM patients. METHODS: We performed 3T CMR scans in 50 HCM patients to assess interstitial fibrosis as expressed by extracellular volume (ECV). In all patients, we determined levels of serum cardiac-specific (troponin T [TnT], N-terminal prohormone of brain natriuretic peptide [NT-proBNP]) and fibrosis-specific (procollagen I C-terminal propeptide, procollagen III N-terminal propeptide, transforming growth factor β1, galectin-3) biomarkers. Patients were divided based on their median value of ECV. RESULTS: The final study population included 49 patients. The median value of ECV in our cohort was 28.1%. Patients stratified according to median ECV differed in terms of several variables: body mass index, late gadolinium extent, NT-proBNP, and galectin-3 levels (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland. akarabinowska@gmail.com.
- Jagiellonian University Medical College, Doctoral School of Medical and Health Sciences, Kraków, Poland. akarabinowska@gmail.com.
- Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland.
- Department of Molecular Biology, John Paul II Hospital, Kraków, Poland.
- Department of Radiology, John Paul II Hospital, Kraków, Poland.
- Students' Scientific Group on Heart Failure, at the Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland.
Zitieren
APA
Karabinowska-Małocha, A., Dziewięcka, E., Szymańska, M., Banyś, P., Urbańczyk-Zawadzka, M., Krupiński, M., Mielnik, M., Wiśniowska-Śmiałek, S., Podolec, P., Budkiewicz, A., Żydzik, Ł., Wypasek, E., & Rubiś, P. (2023). Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy. Kardiologia Polska, 81(7-8), 692-699. https://doi.org/10.33963/kp.a2023.0103
Vancouver
Karabinowska-Małocha A, Dziewięcka E, Szymańska M, Banyś P, Urbańczyk-Zawadzka M, Krupiński M, et al. Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy. Kardiologia Polska. 2023;81(7-8):692-699. doi:10.33963/kp.a2023.0103
BibTeX
@article{KarabinowskaMaocha2023,
author = {Karabinowska-Małocha, Aleksandra and Dziewięcka, Ewa and Szymańska, Magdalena and Banyś, Paweł and Urbańczyk-Zawadzka, Małgorzata and Krupiński, Maciej and Mielnik, Małgorzata and Wiśniowska-Śmiałek, Sylwia and Podolec, Piotr and Budkiewicz, Aleksandra and Żydzik, Łukasz and Wypasek, Ewa and Rubiś, Paweł},
title = {Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy},
journal = {Kardiologia Polska},
year = {2023},
volume = {81},
number = {7-8},
pages = {692--699},
doi = {10.33963/kp.a2023.0103}
}
EUVIMED